Engineered to perform Qualicaps® is a global manufacturer of empty pharmaceutical capsules and pharmaceutical processing equipment. With more than 100 years of experience, Qualicaps is a leader in innovation in both Quali-G™ (gelatin) and Quali-V® (hypromellose) capsules, and offers a proprietary product line of pharmaceutical equipment, including capsule filling, band-sealing and inspection machinery. For more information visit www.qualicaps.com.
External link for Qualicaps
6505 Franz Warner Pkwy
Whitsett, North Carolina 27377, US
Thanks to everyone who stopped by our booth at #INTERPHEX2024 last week. It was a pleasure connecting with you!
The growing demand for capsule-based inhalation pharmaceutical products stems from the rise in respiratory diseases, advancements in drug delivery, and patient preference for convenient inhalation therapy. Explore our exceptional range of specially designed capsules for DPIs: Quali-V®-I capsules. Engineered for inhalation, they boast superior puncturing, moisture control, efficient powder aerosolization, internal lubricant control, and stringent microbiological management, ensuring unparalleled performance in inhalation therapy. Learn more at https://lnkd.in/e9dM9pS6
INTERPHEX is quickly approaching! Join Qualicaps Equipment Division April 16-18, 2024 at Javits Center, NYC. We are thrilled to unveil our journey from legacy banding to the latest excellence of technology in UV laser printing at booth 3416. Register for FREE today! https://lnkd.in/exxDbJWD
Poorly water-soluble drugs present a significant challenge in pharmaceutical development, but over the years lipid-based formulations have emerged offering an innovative way for enhancing drug delivery. Scroll through the slides below to learn more. Find out more how Qualicaps can help with your liquid filled capsule needs by sending us an email today: info@qualicaps.com
We are thrilled to announce the completion of the acquisition of Qualicaps by Roquette, a globally recognized and valued leader in pharmaceutical excipients.
We are pleased to announce the completion of the acquisition of Qualicaps, the third largest producer of hard capsules for oral dosage solutions for the pharmaceutical industry. Relying on high-quality products and a strong innovation pipeline, Qualicaps has a workforce of 1,400 employees located in different sites in Asia, Europe and the Americas. With this acquisition, Roquette will employ around 10,000 people worldwide as we expand our global footprint and pharma offerings for customers. Pierre Courduroux, CEO of Roquette, said: “This acquisition is a key milestone in our journey to reinforce our global leadership in pharmaceutical solutions and to consolidate our position in nutrition and health markets. Thanks to our combined workforce, we will continue to grow our business through collaboration with our customers and to bring our expertise and innovation to all stages of pharmaceutical development.” Find out more in the press release: https://lnkd.in/eMgPs-7U #pharmaindustry #pharmaceuticals #acquisition #innovation
In the midst of a profound transformation within the pharmaceutical and dietary supplement sectors, hard gelatin capsules stand as a cornerstone of this evolution. The slides below underscore the importance of several key factors. Find out how we can help you be transparent with your customers by sending us an email today: info@qualicaps.com #Pharmaceuticals #Wellness #ConsumerTrends
Will we see you in Orlando? Our team is heading to #PharmSci360 in October and we look forward to seeing you there! We will be at booth 3302. Register for #PharmSci360 at https://bit.ly/PharmSci360
Qualicaps is excited about our future with Roquette and the benefits this acquisition will bring to both companies. Stay tuned for great things!
Roquette to acquire Qualicaps Roquette, France based supplier of plant-based ingredients and pharmaceutical excipients, has agreed to acquire Qualicaps, a producer of hard capsules and pharmaceutical processing equipment for oral dosage, and part of the Mitsubishi Chemical Group of Japan. Qualicaps is headquartered in Nara, Japan, and is the third largest producer of hard capsules for oral dosage solutions. The company’s client base includes major pharmaceutical and food companies around the world. Qualicaps operates manufacturing and R&D sites in Japan, Spain, Romania, Canada, the USA and Brazil. Roquette said its knowledge and expertise in the development of pharmaceutical excipients will be further enhanced by Qualicaps’ expertise in capsules, as well as by their assets and infrastructure. Mr. Pierre Courduroux, CEO of Roquette, said, that the deal is a “significant step in Roquette’s journey to reinforce its position as a key player in health and nutrition markets” and Qualicaps’ strong position in hard capsules would represent a significant addition to the company’s excipients’ portfolio. Follow Chemical Weekly page for regular industry updates Subscribe to Chemical Weekly magazine: https://lnkd.in/g3S4ZSu9 #chemicals #chemicalindustry #chemicalweekly #specialitychemicals #chemical #acquisition #capsules #plantbased #ingredients #pharmaceutical #excipients #hardcapsules #processingequipment #food #research #development #rnd #health #nutrition www.chemicalweekly.com Chemical Weekly